Lfa Lugano Financial Advisors Sa Amgen Inc Transaction History

Lfa Lugano Financial Advisors Sa

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 10, 2020	SELL	$197.81 - $242.74 $280,890 - $344,690	-1,420 Closed	0 $0
Q4 2019 Jan 10, 2020	SELL	$189.21 - $243.2 $34,625 - $44,505	-183 Reduced 11.42%	1,420 $342,000
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $4,167 - $4,885	25 Added 1.58%	1,603 $295,000
Q1 2019 Apr 30, 2019	BUY	$180.87 - $203.88 $16,820 - $18,960	93 Added 6.26%	1,578 $299,000
Q3 2018 Oct 11, 2018	BUY	$185.29 - $208.89 $66,148 - $74,573	357 Added 31.65%	1,485 $308,000
Q2 2018 Sep 04, 2018	SELL	$166.05 - $186.51 $34.5 Million - $38.8 Million	-207,963 Reduced 99.46%	1,128 $209,000
Q2 2018 Aug 30, 2018	BUY	$166.05 - $186.51 $34.7 Million - $39 Million	209,091 New	209,091 $209,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Lfa Lugano Financial Advisors Sa, based on Form 13F filings with the SEC.

Stay updated on Lfa Lugano Financial Advisors Sa with notifications on news.